Search

Search Results
Results 2281 - 2290 of 5284 for Active site
  • Drug - 14 Oct 2025
    Consumer Medicine Information (CMI) about Fluorouracil Viatris intended for persons living in Australia.
  • Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Norditropin FlexPro intended for persons living in Australia.
  • Drug - 8 Oct 2025
    Consumer Medicine Information (CMI) about Ovidrel Pen intended for persons living in Australia.
  • Drug - 18 Sep 2025
    Consumer Medicine Information (CMI) about Lonquex intended for persons living in Australia.
  • News - 16 Sep 2025
    Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human...
  • News - 3 Sep 2025
    Compared with crushed ticagrelor, intravenous cangrelor provided immediate, effective platelet inhibition, with no increase in major bleeding and lower mortality rates in patients with acute...
  • Drug - 22 Aug 2025
    Consumer Medicine Information (CMI) about Epipen intended for persons living in Australia.
  • Drug - 22 Aug 2025
    Consumer Medicine Information (CMI) about Epipen Jr intended for persons living in Australia.
  • Drug - 22 Aug 2025
    Consumer Medicine Information (CMI) about Adrenaline Viatris intended for persons living in Australia.
  • Drug - 22 Aug 2025
    Consumer Medicine Information (CMI) about Adrenaline Jr Viatris intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.